Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring

2019

Journal of Hepatology , Volume 70 - Issue 3 p. 552- 554

Additional Metadata
Keywords	Sofosbuvir, Daclatasvir, Hepatitis C, Anti-epileptic drugs, Carbamazepine, Drug interactions, Drug monitoring
Persistent URL	doi.org/10.1016/j.jhep.2018.10.010, hdl.handle.net/1765/115270
Journal	Journal of Hepatology
Organisation	Department of Gastroenterology & Hepatology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Seyen, M., Smolders, EJ, van Wijngaarden, P., Drenth, J., Wouthuyzen-Bakker, M., de Knegt, R., … Burger, D. (2019). Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring. Journal of Hepatology, 70(3), 552–554. doi:10.1016/j.jhep.2018.10.010

Publication